Schizophrenia carries more stigma than almost any other psychiatric diagnosis, and much of that stigma is out of date. It is a treatable brain-based condition, and outcomes are considerably better when treatment starts early and continues consistently, with family involved in the plan.
What is schizophrenia?
Schizophrenia is a treatable brain-based condition affecting thought perception and emotional processing, manageable with consistent treatment.
Schizophrenia is a treatable condition affecting how a person perceives reality, thinks and processes emotion. With consistent treatment many people live stable lives, work and maintain relationships — an outcome that is considerably more common than public perception suggests.
Symptoms are usually described in three groups. Positive symptoms are experiences added to normal functioning: hallucinations, most often hearing voices, and delusions — fixed beliefs held despite evidence. Negative symptoms are things reduced: motivation, emotional expression, speech and social engagement. Cognitive symptoms affect concentration, memory and planning.
The negative and cognitive symptoms are often the most disabling in the long run and the least recognised, since they can be mistaken for laziness or lack of interest. They are part of the condition, not a character trait.
It is worth stating plainly that people with schizophrenia are far more likely to be victims of violence than perpetrators of it. The association with danger is largely a media construction and causes real harm by delaying help-seeking.
What causes schizophrenia?
Schizophrenia results from an interaction between genetic vulnerability and environmental factors affecting brain development. It is not caused by parenting, personal weakness, or anything the person or their family has done — a point worth emphasising, since family guilt is common and unwarranted.
Recognised contributing factors include:
- A family history of schizophrenia or related conditions
- Complications during pregnancy or birth
- Cannabis use, particularly high-potency cannabis in adolescence
- Significant stress or trauma, especially in early life
- Migration and prolonged social adversity
- Older paternal age at conception
Common symptoms
Symptoms vary between people, and you do not need to recognise all of these to benefit from an assessment.
- Hallucinations (hearing or seeing things others don't)
- Delusions (strong false beliefs)
- Disorganised thinking or speech
- Social withdrawal
- Reduced expression of emotion
- Trouble with motivation or daily functioning
When to seek help
Early evaluation is vital if you or a loved one experience unusual thoughts, hear or see things others do not, or withdraw from daily life.
How schizophrenia is diagnosed
Diagnosis is clinical and is not made hastily. It requires a characteristic pattern of symptoms persisting over time, together with a decline in functioning, and the exclusion of other explanations.
The assessment covers the nature and duration of unusual experiences, changes in thinking and behaviour, effects on work, study and relationships, and — with consent — an account from family, who often noticed changes earlier than the person did.
Several conditions must be excluded or identified: substance-induced psychosis, particularly from cannabis or stimulants; bipolar disorder with psychotic features; severe depression with psychosis; and physical causes including certain neurological conditions. Blood tests and brain imaging are commonly arranged as part of this.
Early treatment matters. Longer periods of untreated psychosis are associated with poorer outcomes, so assessment is arranged promptly where psychosis is suspected rather than adopting a wait-and-see approach.
Treatment options
Schizophrenia is treated with a combination of medication, psychological support and practical help with daily functioning. Treatment is long-term, and continuity matters more than intensity.
Antipsychotic medication. This is the foundation of treatment and is effective for most people, particularly for hallucinations and delusions. Different medications suit different people, and finding the right one sometimes takes more than one attempt. Side effects — weight gain, metabolic changes, sedation, movement effects — are discussed openly and monitored, because they are a common and legitimate reason people stop taking medication. Long-acting injectable forms are available where remembering daily tablets is difficult.
Psychological therapy. Cognitive behavioural approaches adapted for psychosis help with managing distressing voices and beliefs, and with the anxiety and depression that frequently accompany the condition. Therapy is offered alongside medication, not instead of it.
Physical health. People with schizophrenia have substantially higher rates of cardiovascular disease and diabetes, partly from medication and partly from reduced access to healthcare. Weight, blood pressure, glucose and lipids are monitored as a routine part of care rather than an afterthought.
Family involvement and daily functioning. Structured family work measurably reduces relapse rates. Families are given information about the condition, guidance on communication, and support in their own right. Practical support with work, study, structure and social contact addresses the negative symptoms that medication alone does not resolve.
What recovery looks like
Outcomes vary considerably. Some people have a single episode and recover fully; many have episodes separated by long periods of stability; a minority have persistent symptoms requiring ongoing support. Early and consistent treatment substantially improves the odds.
The most common cause of relapse is stopping medication, often when feeling well or because of side effects. Side effects are a legitimate reason to change treatment, and raising them leads to adjustment rather than dismissal — stopping abruptly and alone carries a much higher risk than an honest conversation.
Recovery is not measured only by the absence of symptoms. Returning to work or study, maintaining relationships and living independently are the outcomes that matter most to people, and they are realistic goals for many.
Learning to recognise early warning signs — changes in sleep, growing suspicion, withdrawal — allows intervention before a full relapse develops, and is a core part of long-term management.
How Trio Mindspace can help
Dr. Surana partners with patients and families to establish long-term care involving medication management, therapy, and ongoing stability support.
Every plan begins with a full assessment rather than an assumption. Dr. Surana will explain what she thinks is happening, set out the options, and agree the approach with you before anything starts. You can read more about her background and approach, or see all conditions treated at the clinic.
Frequently asked questions
Many people do — working, studying and maintaining relationships — particularly when treatment starts early and continues consistently. Outcomes vary, and the goal set at Trio Mindspace is stability and quality of life, defined around what matters to you.
Considerably. Families often notice early warning signs first, support treatment consistency, and provide the day-to-day stability that protects against relapse. Dr. Surana works with families directly, with the patient's consent, including guidance on what helps and what unintentionally makes things harder.
Usually yes, to prevent relapse. Stopping medication abruptly is one of the most common causes of relapse. Any change is planned and monitored rather than done independently.
A detailed assessment of symptoms, history and current functioning, usually with a family member present if you would like that. Physical causes are ruled out where relevant, and the treatment plan is explained before anything begins.
No. This is one of the most damaging misconceptions about the condition. People with schizophrenia are considerably more likely to be victims of violence than to commit it. Where risk is elevated, it is usually associated with untreated psychosis combined with substance use — which is an argument for prompt treatment, not for fear.
No. This is a common confusion arising from the word's origin. Schizophrenia does not involve multiple personalities. It affects perception, thinking and emotional processing — typically through hallucinations, delusions, reduced motivation and difficulties with concentration.
Often long-term, because its main value is preventing relapse, and the risk of relapse after stopping is high. Duration is discussed openly and reviewed over time rather than assumed. If side effects are a problem, that is a reason to adjust or change treatment — many alternatives exist — rather than to stop without support.
Yes. Many people with schizophrenia work, study and live independently, particularly with consistent treatment and support. Outcomes vary, but the assumption that schizophrenia means permanent incapacity is inaccurate and unhelpful.